Astellas Pharma Inc. - Total Other Finance Cost

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Other-Finance-Cost" stands at -16.72 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Astellas Pharma Inc.'s second quarter result of -2.69 Billion JPY for the item "Total Other Finance Cost" represents an increase of 54.34 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of -2.69 Billion JPY for the item "Total Other Finance Cost" represents an increase of 46.65 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of -16.72 Billion JPY for the item "Total Other Finance Cost" represents an increase of 12.34 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -7.18 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -7.18 Billion Japanese Yens.
The 10 year change is -15.86 Billion Japanese Yens.

The Serie's long term average value is -3.38 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -13.35 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +2.36 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is -16.71 Billion.